In after-hours trading, shares are down 84% to $1.34.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Applied Therapeutics trading resumes
- Applied Therapeutics’ NDA for govorestat receives negative response from FDA
- Applied Therapeutics trading halted, news pending
- Applied Therapeutics price target raised to $13 from $11 at Citi
- RBC says if Applied’s govorestat were to be approved, would likely hear today
Questions or Comments about the article? Write to editor@tipranks.com